tiprankstipranks
Trending News
More News >
Axsome Therapeutics Inc (AXSM)
NASDAQ:AXSM

Axsome Therapeutics (AXSM) Revenue

Compare
2,333 Followers

Axsome Therapeutics Revenue

Axsome Therapeutics had a revenue of 196.00M in the quarter ending Dec 31, 2025, with 14.62%. This bring the company's revenue in the last twelve months to 638.50M, Decreased 13.76%. In the fiscal year ending Dec 31, 2025, Axsome Therapeutics had annual revenue of 638.50M with 65.55% growth.
Revenue (ttm)
638.50M
Revenue Growth
65.83%
P/S Ratio
12.73
Revenue/Employee
$896,764
Employees
712
Market Cap
$8.13B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2025
638.50M252.80M+65.55%
Dec 31, 2024
385.69M115.09M+42.53%
Dec 31, 2023
270.60M220.56M+440.80%
Dec 31, 2022
50.04M+∞%
Dec 31, 2021
Dec 31, 2020
Dec 31, 2019
Dec 31, 2018
Dec 31, 2017